http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107137484-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c19cadc37575bb925e9a0595fdf27d21 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97355e85d4d4ec6e37d14f5bf87bdfab |
| publicationDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107137484-A |
| titleOfInvention | One kind treats prostatitic externally applied liniment and preparation method thereof |
| abstract | Prostatitic externally applied liniment is treated the invention discloses one kind, the raw material composition that prostatitic externally applied liniment is treated per 100mL is as follows：The 83mL of d-Bomeol liquid 79, the 5mL of turpentine oil 4, the 5mL of wintergreen 4, the 11mL of auxiliary agent 9；The auxiliary agent is made up of the raw material below according to parts by weight：7 10 parts of Morinda officinalis, 12 16 parts of barrenwort.The invention also discloses the preparation method of the prostatitic externally applied liniment for the treatment of.The prostatitic externally applied liniment for the treatment of prepared by the present invention has effects that anti-inflammation, promoting blood circulation and removing blood stasis, swelling and pain relieving, can effectively treat prostatitis, effect significantly, and has no toxic side effect, easy to use, is more easy to be received by consumers in general. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111450188-A |
| priorityDate | 2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.